The aim of this study was to evaluate the prevalence of DM among patients with ED and the impact of glycometabolic compensation and antihyperglycemic treatment on ED severity.

Erectile Dysfunction Severity: The Role of Glycometabolic Compensation and Antihyperglycemic Drugs / Zamponi, Virginia; Defeudis, Giuseppe; Federico, Francesca; Faggiano, Antongiulio; Mazzilli, Rossella. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 11:23(2022), p. 7214. [10.3390/jcm11237214]

Erectile Dysfunction Severity: The Role of Glycometabolic Compensation and Antihyperglycemic Drugs

Zamponi, Virginia;Defeudis, Giuseppe;Faggiano, Antongiulio;Mazzilli, Rossella
2022

Abstract

The aim of this study was to evaluate the prevalence of DM among patients with ED and the impact of glycometabolic compensation and antihyperglycemic treatment on ED severity.
2022
GLP1; PDE5-i; SGLT2; antihyperglycemic drugs; diabetes mellitus; erectile dysfunction
01 Pubblicazione su rivista::01a Articolo in rivista
Erectile Dysfunction Severity: The Role of Glycometabolic Compensation and Antihyperglycemic Drugs / Zamponi, Virginia; Defeudis, Giuseppe; Federico, Francesca; Faggiano, Antongiulio; Mazzilli, Rossella. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 11:23(2022), p. 7214. [10.3390/jcm11237214]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1662792
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact